Rate per 100,000 Population of Reported Cases by Age Group - 2013

  <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60+ Total
AIDS* 0.0 0.0 0.0 0.4 0.7 6.3 8.3 10.4 6.0 2.1 4.7
AMEBIASIS 0.0 1.2 0.7 0.8 0.7 1.6 1.7 1.4 0.9 0.5 1.1
ANAPLASMOSIS 0.0 0.6 1.3 1.1 0.6 1.8 2.5 2.6 6.2 9.4 4.0
BABESIOSIS 0.0 0.0 0.3 0.3 0.4 0.9 2.0 3.7 6.2 10.5 4.1
BRUCELLOSIS 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.04 0.04
CAMPYLOBACTERIOSIS 33.5 29.8 13.4 10.0 16.0 19.6 17.4 18.4 20.4 21.2 19.0
CHLAMYDIA NA NA NA 59.3 1367.0 1447.2 288.4 60.5 19.8 3.4 337.6
CRYPTOSPORIDIOSIS 2.5 8.5 3.3 1.9 3.6 3.8 2.5 1.4 0.8 0.8 2.2
CYCLOSPORA 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.04 0.1
DENGUE FEVER 0.0 0.2 0.3 0.7 0.2 0.6 0.2 0.6 0.7 0.5 0.5
E. COLI 0157 0.0 2.8 2.1 0.6 0.9 0.7 0.1 0.4 0.2 0.3 0.6
EHEC** 2.5 5.8 1.3 1.8 3.3 1.2 0.9 0.3 0.6 0.9 1.3
EHRLICHIOSIS 0.0 0.0 0.1 0.1 0.5 0.6 0.5 1.0 0.8 1.7 0.8
EHRLICHIOSIS/ANAPLASMOSIS UNDETERMINED 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.2 0.2 0.2
ENCEPHALITIS (NON-WESTNILE) 1.7 0.8 0.1 0.3 0.4 0.6 0.4 0.4 0.4 0.9 0.5
GIARDIASIS 4.2 18.5 11.0 7.3 8.0 8.8 7.7 7.3 9.9 8.7 9.0
GONORRHEA NA NA NA 7.9 165.6 229.1 79.9 26.4 12.5 1.8 57.5
HAEMOPHILUS INFLUENZAE 6.7 1.6 0.6 0.1 0.5 0.2 0.1 0.9 1.4 4.9 1.6
HEMOLYTIC UREMIC SYNDROME 0.0 1.4 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1
HEPATITIS A 0.0 0.6 0.0 0.4 1.1 1.0 0.8 0.9 0.7 0.4 0.7
HEPATITIS B - ACUTE 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.8 0.8 0.4 0.4
HEPATITIS B - CHRONIC*** 0.0 0.6 0.6 1.4 5.2 17.5 34.5 21.5 17.0 12.5 15.0
HEPATITIS C - ACUTE 0.0 0.0 0.0 0.0 0.6 4.0 2.4 0.9 0.4 0.0 1.0
HEPATITIS C, PAST/PRESENT*** 0.8 1.2 0.3 0.6 12.1 76.1 69.5 51.1 98.9 52.2 52.1
HIV*** 0.8 0.0 0.0 0.6 4.3 20.2 17.0 12.9 8.7 2.6 8.6
LABORATORY CONFIRMED INFLUENZA 672.3 445.1 349.3 169.8 125.5 131.5 131.9 101.0 94.4 170.6 174.3
LEGIONELLOSIS 0.0 0.0 0.0 0.0 0.0 0.7 2.5 3.1 6.7 10.5 4.1
LISTERIOSIS 1.7 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.4 1.9 0.6
MALARIA 0.0 0.6 0.1 0.3 0.4 0.6 0.5 0.9 0.7 0.4 0.5
MEASLES 0.8 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.03
MENINGITIS ASEPTIC 51.1 1.4 1.8 3.0 3.1 3.6 3.4 2.4 1.7 1.8 3.0
MENINGOCOCCAL 1.7 0.4 0.3 0.0 0.4 0.2 0.0 0.2 0.1 0.3 0.2
MENINGITIS OTHER BACT. AND UNKNOWN 5.9 0.2 0.3 0.3 0.5 0.3 0.2 0.6 0.7 0.9 0.6
MUMPS 0.0 0.2 0.0 0.0 0.2 0.3 0.1 0.0 0.1 0.0 0.1
PERTUSSIS 62.9 15.7 18.9 27.0 16.1 1.5 1.9 1.9 1.1 0.8 6.4
Q FEVER 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.04 0.01
RMSF 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.2 0.3 0.3 0.2
SALMONELLOSIS 56.2 23.7 10.3 10.5 9.9 12.7 10.8 7.8 10.3 11.1 11.6
SHIGELLOSIS 1.7 11.1 8.6 3.2 1.1 2.1 2.4 1.1 1.2 0.8 2.4
STREP GROUP A INVASIVE 5.0 2.3 2.4 0.7 0.9 1.2 2.2 1.8 2.3 6.8 2.9
STREP GROUP B INVASIVE 53.7 0.2 0.4 0.0 0.4 1.1 3.3 5.0 8.8 27.0 9.0
STREP PNEUMONIA INVASIVE***** 9.2 8.0 1.6 1.7 0.7 1.8 2.9 4.9 10.1 26.3 9.1
SYPHILIS EARLY NA NA NA 0.0 2.7 12.8 9.4 6.3 3.4 0.7 4.5
SYPHILIS LATE NA NA NA 0.0 0.5 4.2 6.2 8.6 7.1 5.9 4.8
TETANUS 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.01
TOXIC SHOCK SYNDROME 0.0 0.2 0.0 0.1 0.4 0.0 0.2 0.1 0.0 0.2 0.1
TRICHINOSIS 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.02
TUBERCULOSIS 0.8 1.0 0.1 0.0 0.6 2.7 3.9 1.3 2.1 2.6 1.9
TYPHOID FEVER 0.0 0.0 0.1 0.3 0.2 0.4 0.0 0.3 0.0 0.04 0.1
WEST NILE FEVER 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.1
WEST NILE VIRUS 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.1
YERSINIOSIS 0.8 1.0 0.1 0.3 0.1 0.2 0.3 0.3 0.5 0.8 0.4

Footnotes

  • * Based on year reported (excludes inmates). Includes all newly-reported AIDS cases regardless of HIV diagnosis date.
    Provisional, data as of July 7, 2014. County of residence is unknown for 9 cases.
  • **E.coli non-O157 and non-sero-grouped shigatoxin producing infection
  • *** Rate per cases as of September 25, 2014. Excludes inmates.
  • **** Based on year reported (excludes inmates). Includes all newly-reported HIV cases, regardless of concurrent or subsequent AIDS diagnosis.
    Provisional, data as of August 8, 2013.
  • *****Resistant, Sensitive, Intermediate, & Unknown